Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.
about
BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting AktSBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation ComplexCooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
P2860
Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.
@en
Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.
@nl
type
label
Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.
@en
Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.
@nl
prefLabel
Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.
@en
Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.
@nl
P2093
P2860
P356
P1476
Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.
@en
P2093
Elisa Barile
Maurizio Pellecchia
Surya K De
Yongmei Feng
P2860
P304
P356
10.1111/CBDD.12177
P50
P577
2013-09-25T00:00:00Z